Ovarian Cancer Trial, Not Yet Recruiting NCT06283875 Sponsor: Geneplus-Beijing Co. Ltd. Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT06283875
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with stage IB to IVA cervical cancer, confirmed by a tissue sample test, using the 2018 FIGO staging system.
  • People whose treating doctor determines they are able to have surgery, or full-course radiation therapy and chemotherapy.
  • People aged between 18 and 80 years old.
  • People who have a general health score of ECOG 0–2, meaning they are able to carry out daily activities with little to no limitation (confirm with trial site).
  • People who have at least one tumour that can be measured using standard imaging criteria (RECIST 1.1).
  • People who are able to understand the research plan, are willing to take part, and have signed a consent form.
  • People who are willing and able to cooperate with sample collection at various points and provide relevant health information.
  • People who have complete imaging and pathology records available.
  • People whose doctor estimates they have a life expectancy of more than 3 months.
  • People whose organ and bone marrow function is at a sufficient level to take part (confirm with trial site).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with another cancer, or who have had cervical cancer return or spread, within the past 5 years.
  • People who have already received any treatment for their tumour.
  • People who are not able to have surgery, or full-course radiation therapy and chemotherapy.
  • People who are not able to attend follow-up appointments as required by the study schedule.
  • People who are unable to have or provide results from required assessment methods such as CT scans.
  • People who have an autoimmune disease.
  • People who have a history of psychiatric medication misuse that they have not been able to stop, or who have a diagnosed mental disorder.
  • People who have any severe or uncontrolled medical condition.
  • People who, in the opinion of the research team, have other health conditions that could seriously affect their safety or their ability to complete the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jinhua Zhou, The First Affiliated Hospital of Soochow University,Director of Gynecology Department

Phone: +86 13914024750

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Geneplus-Beijing Co. Ltd.
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
30 January 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

DFS of enrolled patients for 2 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov